• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Battery Ventures Acquires Analytical-Instrumentation Pioneer LI-COR Biosciences

Share:

December 13, 2021

Battery Ventures, a global, technology focused investment firm, has acquired LI-COR Biosciences, an industry-leading company that makes highly engineered instrumentation systems for environmental research, agriculture, drug discovery, protein research and therapeutics development.

LI-COR, founded by Bill and Elaine Biggs, has two main business lines: environmental-monitoring instrumentation, including devices and software for scientists to analyze plants, atmospheric qualities, gas and soil, and a biotechnology business, offering a portfolio of imaging and analysis instruments, proprietary software and reagents sold mainly to life-science research institutions and pharmaceutical producers.

An increased need for climate-change analysis and adaptation, as well continued global population growth and the need to improve food production, are larger trends pushing the adoption of LI-COR’s environmental products. LI-COR’s biotechnology products help researchers improve the human condition through innovative research tools that help scientists solve global health challenges. Based in Lincoln, Neb., the company counts more than 3,000 academic and commercial customers across 100 countries and operates two subsidiaries in Germany and the United Kingdom.

“We are excited to partner with LI-COR and the Biggs family in this transaction, particularly since we’ve been tracking the company and its growth since 2013,” said Jesse Feldman, a Battery Ventures general partner. “We look forward to helping LI-COR increase its market share and grow both organically and through targeted acquisitions.” Feldman and Battery’s Max-Julian Kaye are joining LI-COR’s board.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

As part of the acquisition, current LI-COR Chief Executive Greg Biggs, the son of co-founder Bill Biggs, will transition to an advisory role. Thomas Reslewic, a current Battery executive-in-residence who previously served as group president for two business units within Teledyne Technologies, will become CEO. At Teledyne, Reslewic managed a portfolio of companies producing a range of scientific instruments, environmental-monitoring equipment, and test-and-measurement solutions, among other products.

“LI-COR has incredibly strong heritage as an innovator in both of its core markets, which continue to present exciting opportunities for organic and inorganic growth,” Reslewic said. “I am excited to assume this new role and to lead LI-COR in its next chapter of growth as a category leader.”

Greg Biggs noted: “Partnering with Battery, a well-capitalized firm with an extensive history of backing innovative analytical-instrument businesses, is the logical evolution for LI-COR. We could not be more thrilled to leverage Battery’s capital, network and industry expertise to continue to drive our growth in this dynamic industry environment.”

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Cognoa and EVERSANA™ Announce Partnership to Advance the Commercialization Standard for Prescription Digital MedicinesCognoa and EVERSANA™ Announce Partnership to Advance the Commercialization Standard for Prescription Digital Medicines
  • Global Life Sciences Automation Market Size and Growth 2022 Research Report By Swot Analysis, Trends, Recent Development and Forecast to 2026Global Life Sciences Automation Market Size and Growth 2022 Research Report By Swot Analysis, Trends, Recent Development and Forecast to 2026
  • Fitbit, Scripps, Stanford to Study Role of Wearables to Detect, Train, and Contain Infectious DiseasesFitbit, Scripps, Stanford to Study Role of Wearables to Detect, Train, and Contain Infectious Diseases
  • The Case for Integrating Telemedicine Education Into Medical CurriculumsThe Case for Integrating Telemedicine Education Into Medical Curriculums
  • Novartis Partners with SHYFT to Support its Digital TransformationNovartis Partners with SHYFT to Support its Digital Transformation
  • Click Therapeutics Shares 2022 Accomplishments and Development Progress in its Prescription Digital Therapeutics ProgramsClick Therapeutics Shares 2022 Accomplishments and Development Progress in its Prescription Digital Therapeutics Programs
  • BrightInsight Nabs $25M For Regulated IoT Platform For Biopharma And MedtechBrightInsight Nabs $25M For Regulated IoT Platform For Biopharma And Medtech
  • Securing, controlling and monetising genomic data with blockchain technologySecuring, controlling and monetising genomic data with blockchain technology

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications